Amundi Asset Management US’s Cantel Medical Corporation CMD Stock Holding History

Amundi Asset Management US’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-139	Closed	-$6K	–	1633
2020 Q3	$6K	Hold	139	–	–	﹤0.01%	1568
2020 Q2	$6K	Buy	139 +69	+99%	+$2.57K	﹤0.01%	1587
2020 Q1	$3K	Sell	70 -1,886	-96%	-$107K	﹤0.01%	1582
2019 Q4	$139K	Hold	1,956	–	–	﹤0.01%	1532
2019 Q3	$146K	Hold	1,956	–	–	﹤0.01%	1523
2019 Q2	$158K	Hold	1,956	–	–	﹤0.01%	1511
2019 Q1	$131K	Hold	1,956	–	–	﹤0.01%	1514
2018 Q4	$146	Hold	1,956	–	–	﹤0.01%	1440
2018 Q3	$180K	Buy	1,956 +689	+54%	+$65.6K	﹤0.01%	1464
2018 Q2	$125K	Buy	+1,267	New	+$142K	﹤0.01%	1457

Other funds holding CMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

LGP

Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Amundi Asset Management US's CMD Position: Q4 2020 in Review

Amundi Asset Management US sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 139 shares — an estimated $6K sold.

Amundi Asset Management US first reported a position in CMD in Q2 2018 and held it in 10 quarters. The position peaked at $180K in Q3 2018. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

Amundi Asset Management US reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
Amundi Asset Management US sold 139 Cantel Medical Corporation shares in Q4 2020, an estimated $6K.
Amundi Asset Management US first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 10 quarters.
Amundi Asset Management US's Cantel Medical Corporation position peaked at $180K in Q3 2018.
229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Amundi Asset Management US's 13F filing for Q4 2020, filed 16 Feb 2021.